Evaluation of Docking Performance: Comparative Data on Docking Algorithms

Journal of Medicinal Chemistry

Volumn 47, Issue 3, 2004, Pages 558-565

  Kontoyianni, Maria ^a   McClellan, Laura M ^a   Sokol, Glenn S ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PROTEIN;

ACCURACY; ALGORITHM; ARTICLE; BINDING SITE; COMPUTER AIDED DESIGN; COMPUTER PREDICTION; COMPUTER PROGRAM; CONFORMATION; CRYSTALLOGRAPHY; DOCKING; DRUG DESIGN; INTERMETHOD COMPARISON; LIGAND BINDING; PERFORMANCE; PROTEIN FAMILY; TECHNIQUE;

ALGORITHMS; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; LIGANDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEIN BINDING; PROTEINS;

EID: 1642540577     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0302997     Document Type: Article

References (36)

1. Morris, G. M.; Olson, A. J.; Goodsell, D. S. Protein-ligand docking. Methods Princ. Med. Chem. 2000, 8, 31-48.
2. Mestres, J.; Knegtel, R. M. A. Similarity versus docking in 3D virtual screening. Perspect. Drug Discovery Des. 2000, 20, 191-207.
3. Vieth, M.; Hirst, J. D.; Dominy, B. N.; Daigler, H.; Brooks, C. L., III. Assessing search strategies for flexible docking. J. Comput. Chem. 1998, 19, 1623-1631.
4. Gilson, M. K.; Given, J. A.; Bush, B. L.; McCammon, J. A. The statistical-thermodynamic basis for computation of binding affinities: a critical review. Biophys. J. 1997, 72, 1047-1069.
5. Monard, G.; Merz Jr. K. M. Combined Quantum Mechanical/Molecular Mechanical Methodologies Applied to Biomolecular Systems. Acc. Chem. Res. 1999, 32, 904-911.
6. Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and validation of a genetic algorithm to flexible docking. J. Mol. Biol. 1997, 267, 727-748.
7. Rarey, M.; Kramer, B.; Lengauer, T.; Klebe, G. A. A fast flexible docking method using an incrememental construction algorithm. J. Mol. Biol. 1996, 261, 470-89.
8. Kuntz, I. D.; Blaney, J. M.; Oatley, S. J.; Langidge, R.; Ferrin, T. E. A geometric approach to macromolecule-ligand interactions. J. Mol. Biol. 1982, 161, 269-288.
9. Schrödinger, Portland, OR 97201.
10. Venkatachalam, C. M.; Jiang, X.; Oldfield, T.; and Waldan, M. LigandFit: A novel method for the shape-directed rapid docking of ligands to protein active sites. J. Mol. Graphics Modell. 2003, 21, 289-307.
11. Bissantz, C.; Folkers, G.; Rognan, D. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. J. Med. Chem. 2000, 43, 4759-4767.
12. Kramer, B.; Rarey, M.; Lengauer, T. Evaluation of the FlexX incremental construction algorithm for protein-ligand docking. Proteins 1999, 37, 228-241.
13. Nissink, J.; Willem, M.; Murray, C.; Hartshorn, M.; Verdonk, M. L.; Cole, J. C.; Taylor, R. A new test set for validating predictions of protein-ligandinteraction. Proteins: Struct., Funct., and Genet. 2002, 49, 457-471.
14. Hopkins, S. C.; Vale, R. D.; Kuntz, I. D. Inhibitors of kinesin activity from structure-based computer screening. Biochemistry 2000, 39, 2805-2814.
15. Debnath, A. K.; Radigan, L.; Jiang, S. Structure-bases identification of small molecule antiviral compounds targeted to the gp41 core of the human immunodeficiency virus type. J. Med. Chem. 1999, 42, 3203-3209.
16. Bodian, D. L.; Yamasaki, R. B.; Buswell, R. L.; Stearns, J. F.; White, J. M.; Kuntz, I. D. Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. Biochemistry 1993, 32, 2967-2978.
17. Shoichet, B. K.; Stroud, R. M.; Santi, D. V.; Kuntz, I. D.; Perry, K. M. Structure-based discovery of inhibitors of thymidylate synthase. Science 1993, 259, 1445-50.
18. Arorov, A. M.; Munagal, N. R.; Ortiz De Montellano, P. R.; Kuntz, I. D.; Wang, C. C. Rational design of selective submicromolar inhibitors of tritrichomonas foetus hypoxanthine-guanine-xanthine phosphoribosyltransferase. Biochemistry 2000, 39, 4684-91.
19. Chen, Q.; Shafer, R. H.; Kuntz, I. D. Structure-based discovery of ligands targeted to the RNA double helix. Biochemistry 1997, 36, 11402-11407.
20. Gschwend, D. A.; Sirawaraporn, W.; Santi, D. V.; Kuntz, I. D. Specificity in structure-based drug design: identification of a novel, selective inhibitor of Pneumocystis carinii dihydrofolate reductase. Proteins 1997, 29, 59-67.
21. Checa, A.; Ortiz, A. R.; de Parscual-Teresa, B.; Gago, F. Assessment of solvation effects on calculated binding affinity differences: trypsin inhibition by flavonoids as a model system for congeneric series. J. Med. Chem. 1997, 40, 4136-4145.
22. Dixon, J. S. Evaluation of the CASP2 docking section. Proteins 1997, Suppl. 1, 198-204.
23. Charifson, P. S.; Corkery, J. J.; Murcko, M. A.; Walters, W. P. Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. J. Med. Chem. 1999, 42, 5100-5109.
24. Clark, R. D.; Strizhev, A.; Leonard, J. M.; Blake, J. F.; Matthew, J. B. Consensus scoring for ligand/protein interactions. J. Mol. Graphics Modell. 2002, 20, 281-295.
25. Stahl, M.; Rarey, M. Detailed analysis of scoring functions for virtual screening. J. Med. Chem. 2001, 44, 1035-1042.
26. Wang, R.; Wang, S. How does consensus scoring work for virtual library screening? An idealized computer experiment. J. Chem. Inf. Comput. Sci. 2001, 41, 1422-1426.
27. Hagler, A. T.; Ewig, C. S. On the use of quantum energy surfaces in the derivation of molecular force fields. Comput. Phys. Commun. 1994, 84, 131-155.
28. Jwang, M.-J.; Stockfisch, T. P.; Hagler, A. T. Derivation of class II force fields. 2. Derivation and characterization of a class II force field, CFF93, for the alkyl functional group and alkane molecules. J. Am. Chem. Soc. 1994, 116, 2515-2525.
29. Rappe, A. K.; Goddard, W. A., III. Charge equilibration for molecular dynamics simulations. J. Phys. Chem. 1991, 63, 867-872.
30. Adrea Mehl, private communication.
31. Gehlhaar, D. K.; Verkhivker, G. M.; Rejto, P. A.; Sherman, C. J.; Fogel, D. B.; Fogel, L. J.; Freer, S. T. Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming. Chem. Biol. 1995, 2, 317-324.
32. Gehlhaar, D. K.; Moeerder, K. E.; Zichi, D.; Sherman, C. J.; Ogden, R. C.; Freer, S. T. De novo design of enzyme inhibitors by monte carlo ligand generation. J. Med. Chem. 1995, 38, 466-472.
33. Gehlhaar, D. K.; Bouzida, D.; Rejto, P. A. Rational Drug Design: Novel Methodology and Practical Applications; Parrill, L., Reddy, M. R., Eds.; ACS Symposium Series 719; American Chemical Society: Washington, DC, 1999; pp 292-311.
34. Böhm, H. J. The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structures. J. Comput.-Aided Mol. Des. 1994, 7, 385-391.
35. Muegge, I.; Martin, Y. C. A general and fast scoring function for protein-ligand interactions: A simplified potential approach. J. Med. Chem. 1999, 42, 791-804.
36. Connolly, M. L. Analytical molecular surface calculation J. Appl. Crystallogr. 1983, 16, 548-558.